Sakamoto, T., Leca, J., Zhang, X., Meydan, C., Foox, J., Ramachandran, P., Hendrikse, L. D., Zhou, W., Berger, T., Fortin, J., Chan, S. M., Chiang, M., Inoue, S., Li, W. Y., Chu, M. F., Duncan, G. S., Wakeham, A., Lemonnier, F., Tobin, C., Mcwilliam, R., Colonna, I., Bontoux, C., Jafari, S. M., Bowman, R. L., Nicolay, B., Ronseaux, S., Narayanaswamy, R., Levine, R. L., Melnick, A. M., Mason, C. E., Minden, M. D., Mak, T. W. (2025). Mutant
                    <i>IDH1</i>
                    cooperates with
                    <i>NPM1c</i>
                    or
                    <i>FLT3</i>
                    <sup>ITD</sup>
                    to drive distinct myeloid diseases and molecular outcomes. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2415779122